ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

ClinicalTrials.gov ID: NCT05555732

Public ClinicalTrials.gov record NCT05555732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 9:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in Subjects With No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung07)

Study identification

NCT ID
NCT05555732
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
1,170 participants

Conditions and interventions

Interventions

  • Carboplatin Drug
  • Cisplatin Drug
  • Datopotamab Deruxtecan Drug
  • Pembrolizumab Drug
  • Pemetrexed Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 10, 2023
Primary completion
May 10, 2029
Completion
May 10, 2029
Last update posted
Mar 24, 2026

2023 – 2029

United States locations

U.S. sites
36
U.S. states
14
U.S. cities
35
Facility City State ZIP Site status
Southern Cancer Center Pc Daphne Alabama 36526
Ironwood Cancer and Research Centers Chandler Arizona 85224
Arizona Oncology Associates, Pc - Nahoa Prescott Valley Arizona 86314
Hoag Memorial Hospital Prebyterian Newport Beach California 92663
Compassionate Cancer Care Medical Group Riverside California 92501
Sansum Clinic Santa Barbara California 93105
Ronald Reagan UCLA Medical Center Santa Monica California 90404
UCHealth Memorial Hospital Colorado Springs Colorado 80909
Florida Cancer Specialists - South Fort Myers Florida 33901
Cancer Specialist of North Florida Jacksonville Florida 32256
Cancer Care Centers of Brevard, Inc. Palm Bay Florida 32901
Woodlands Medical Specialists, Pa Pensacola Florida 32503
Florida Cancer Specialists-North St. Petersburg Florida 33705
Emory University - Winship Cancer Institute Wci Atlanta Georgia 30322-1013
Illinois Cancer Specialists Niles Illinois 60714
American Oncology Partners of Maryland Bethesda Maryland 20817
Maryland Oncology Heamtology P.A. Columbia Maryland 21044
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Dana Farber Cancer Institute; Inv Drg Svc Pharm Boston Massachusetts 02215
Dana Farber Cancer Institute At St. Elizabeth'S Medical Center Brighton Massachusetts 02135
Dana Farber Brigham Cancer Center Foxborough Massachusetts 02035
Dana Farber At Milford Regional Cancer Center Milford Massachusetts 01757
Dana Farber/Bwcc in Affiliation With South Shore Hospital South Weymouth Massachusetts 02190
Astera Cancer Care East Brunswick New Jersey 08816
Regional Cancer Care Associates LLC Hackensack New Jersey 07601
North Shore Hematology Oncology Associates dba NY Cancer and Blood Specialists- New Hyde Park New Hyde Park New York 11042
North Shore Hematology Oncology Associates Patchogue New York 11772
North Shore Hematology Oncology Associates DBA NY Cancer and Blood Specialists Port Jefferson Station New York 11776
North Shore Hematology Oncology Associates dba NY Cancer and Blood Specialists - Bronx The Bronx New York 10469
Texas Oncology, P.A. McAllen Texas 78503
Ut Health San Antonio San Antonio Texas 78229
Texas Oncology, P.A. Sugar Land Texas 77479
Texas Oncology-Tyler Tyler Texas 75702
Utah Cancer Specialists IHO Corp Salt Lake City Utah 84106
Providence Regional Cancer System Lacey Washington 98503
VA Puget Sound Health Care System Seattle Washington 98108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 218 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05555732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05555732 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →